HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY Article

CARTER, P, PRESTA, L, GORMAN, CM et al. (1992). HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY . PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 89(10), 4285-4289. 10.1073/pnas.89.10.4285

Open Access

cited authors

  • CARTER, P; PRESTA, L; GORMAN, CM; RIDGWAY, JBB; HENNER, D; WONG, WLT; ROWLAND, AM; KOTTS, C; CARVER, ME; SHEPARD, HM

sustainable development goals

authors

publication date

  • May 15, 1992

published in

keywords

  • ANTIBODY ENGINEERING
  • C-ERBB-2
  • EGF RECEPTOR
  • GENE
  • GROWTH-FACTOR RECEPTOR
  • HUMAN-BREAST
  • HYPERVARIABLE REGIONS
  • IMMUNOGLOBULINS
  • MONOCLONAL-ANTIBODY
  • Multidisciplinary Sciences
  • NEU
  • NEU ONCOGENE
  • RESHAPING HUMAN-ANTIBODIES
  • SITE-DIRECTED MUTAGENESIS
  • Science & Technology
  • Science & Technology - Other Topics
  • TUMOR NECROSIS FACTOR

Digital Object Identifier (DOI)

publisher

  • NATL ACAD PRESS

start page

  • 4285

end page

  • 4289

volume

  • 89

issue

  • 10